Edesa Biotech - Stock Price History | EDSA

Historical daily share price chart and data for Edesa Biotech since 2021 adjusted for splits. The latest closing stock price for Edesa Biotech as of September 27, 2021 is 8.00.
  • The all-time high Edesa Biotech stock closing price was 395.02 on November 05, 2015.
  • The Edesa Biotech 52-week high stock price is 12.00, which is 50% above the current share price.
  • The Edesa Biotech 52-week low stock price is 4.05, which is 49.4% below the current share price.
  • The average Edesa Biotech stock price for the last 52 weeks is 5.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Edesa Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.7169 4.0900 9.4500 1.6400 4.2500 3.66%
2019 5.8772 5.7349 11.6977 3.3900 4.1000 -24.89%
2018 17.7518 35.7241 41.5592 5.0390 5.4589 -83.95%
2017 56.6727 86.8965 90.6747 33.5832 34.0072 -60.09%
2016 150.2678 275.3823 287.5562 78.5007 85.2174 -68.72%
2015 331.5298 395.0225 395.0225 272.4438 272.4438 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.106B $0.000B
Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29